Comparison of CL Wear Between Two Allergy Drops

Comparison of CL Wear Between Epinastine Hydrochloride and Olopatadine Hydrochloride

Status

Withdrawn

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00489398

Enrollment

Registered

2007-06-21

Start date

2007-07-31

Completion date

2008-12-31

Last updated

2010-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Conjunctivitis

Brief summary

Comparison of two allergy drops for enhancing comfort and performance of contact lens wear

Detailed description

Contact lens patients will instill allergy drops and subjective and objective tests will be performed

Interventions

DRUGepinastine HCL and olopatadine HCL

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

SINGLE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Males or females \> 18 years old * Mild to moderate dry eye symptoms * Likely to complete all study visits and able to provide informed consent

Exclusion criteria

* Current use of topical cyclosporine * Known contraindications to any study medication or ingredients * Active ocular diseases or uncontrolled systemic disease (blepharitis patients that are actively being treated or disease that is uncontrollable) * Ocular surgery within the past 3 months

Design outcomes

Primary

Measure	Time frame
Contact lens objective and subjective clinical performance testing	up to 3 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026